Johnson & Johnson to pay $8 Billion after man grows breasts.

Giant US drug firm has been ordered to pay an eye watering $8 Billion after failing to warn that an anti-psychotic drug could lead to breast growth.

A Philadelphia jury made the award to Nicholas Murray, 26, whose case was one of thousands pending in the state.

His lawyers argued J&J’s subsidiary Janssen put “profits over patients” in marketing the drug Risperdal.

J&J will appeal the ruling, which it said was “grossly disproportionate”.